中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
36期
13-14
,共2页
妇炎康复胶囊%甲硝唑%慢性盆腔炎
婦炎康複膠囊%甲硝唑%慢性盆腔炎
부염강복효낭%갑초서%만성분강염
Fuyan Kangfu Capsule%Metronidazole%Chronic pelvic inflammatory disease
目的：探讨妇炎康复胶囊联合甲硝唑治疗慢性盆腔炎的临床疗效。方法选择该院2012年4月—2014年5月收治的84例慢性盆腔炎患者作为研究对象，随机分为对照组42例和观察组42例，对照组行甲硝唑氯化钠静脉滴注治疗，观察组行甲硝唑氯化钠静脉滴注后加用妇炎康复胶囊，对两组患者治疗效果及治疗安全性进行分析。结果观察组治疗有效率为92.86%，对照组有效率为71.43%，观察组显著优于对照组，差异有统计学意义（P<0.05)；观察组不良反应发生率明显低于对照组，而输卵管造影正常率显著高于对照组，差异有统计学意义（P<0.05)。结论对慢性盆腔炎患者采取妇炎康复胶囊联合甲硝唑治疗，疗效显著，安全性高，可提高输卵管正常率，值得临床进一步推广使用。
目的：探討婦炎康複膠囊聯閤甲硝唑治療慢性盆腔炎的臨床療效。方法選擇該院2012年4月—2014年5月收治的84例慢性盆腔炎患者作為研究對象，隨機分為對照組42例和觀察組42例，對照組行甲硝唑氯化鈉靜脈滴註治療，觀察組行甲硝唑氯化鈉靜脈滴註後加用婦炎康複膠囊，對兩組患者治療效果及治療安全性進行分析。結果觀察組治療有效率為92.86%，對照組有效率為71.43%，觀察組顯著優于對照組，差異有統計學意義（P<0.05)；觀察組不良反應髮生率明顯低于對照組，而輸卵管造影正常率顯著高于對照組，差異有統計學意義（P<0.05)。結論對慢性盆腔炎患者採取婦炎康複膠囊聯閤甲硝唑治療，療效顯著，安全性高，可提高輸卵管正常率，值得臨床進一步推廣使用。
목적：탐토부염강복효낭연합갑초서치료만성분강염적림상료효。방법선택해원2012년4월—2014년5월수치적84례만성분강염환자작위연구대상，수궤분위대조조42례화관찰조42례，대조조행갑초서록화납정맥적주치료，관찰조행갑초서록화납정맥적주후가용부염강복효낭，대량조환자치료효과급치료안전성진행분석。결과관찰조치료유효솔위92.86%，대조조유효솔위71.43%，관찰조현저우우대조조，차이유통계학의의（P<0.05)；관찰조불량반응발생솔명현저우대조조，이수란관조영정상솔현저고우대조조，차이유통계학의의（P<0.05)。결론대만성분강염환자채취부염강복효낭연합갑초서치료，료효현저，안전성고，가제고수란관정상솔，치득림상진일보추엄사용。
Objective To investigate and analyze the clinical effects of Fuyan Kangfu Capsule combined with Metronidazole on chronic pelvic inflammatory disease. Methods 84 patients who suffered from the chronic pelvic inflammatory disease accepted treatments in our hospital from April, 2012 to May, 2014 were taken as the research objects. And these patients were randomly di-vided into the control group and the observation group, with 42 patients in each group. In the control group, the patients were treated with intravenous drip of Metronidazole and Sodium Chloride Injection, while in the observation group, the patients were given Fuyan Kangfu Capsule after intravenous drip of Metronidazole and Sodium Chloride Injection. And the curative effects and safety of these two groups of patients were analyzed. Results The response rate in the observation group was 92.86%, and that in the control group was 71.43%, which indicated that the treatment effect of the observation group was evidently better than that of the control group (P<0.05). In addition, the incidence of adverse reactions in the observation group was obviously lower than that in the control group while the negative rate of salpingography in the observation group was evidently higher than that in the control group and the differences had the statistical significance (P<0.05). Conclusion For chronic pelvic inflammatory disease, Fuyan Kangfu Capsule combined with Metronidazole has significant effect with high safety, which can improve the negative rate of fallopi-an tube, thus it is worthy of further application and promotion in the clinical practice.
